Dr. Tony Chen, MD

Dr. Chen practices at Stanford Care Digestive Health Center of Pleasanton - HOPD in Pleasanton, California.

Dr. Chen's NPI, 1013335512, was assigned on April 1, 2014. Dr. Chen graduated from UC San Diego School of Medicine in 2014. Dr. Chen's California license number on file is A166904.

Dr. Chen's primary practice is Stanford Care Digestive Health Center of Pleasanton - HOPD, at 5565 W Las Positas Blvd, Pleasanton, CA 94588.

Dr. Chen's primary practice is Stanford Care Digestive Health Center of Pleasanton - HOPD in Pleasanton, California. Dr. Chen is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Chen to 2 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chen practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Chen's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Chen is board certified in urology by the American Board of Urology. Dmand AI has Dr. Chen's licenses on file in 2 states: California and Washington.

Dmand AI lists enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney removal surgery, kidney stone disease, prostate cancer, testicular dysfunction and urinary endoscopy among the conditions Dr. Chen treats.

CMS data shows 540 Medicare services from Dr. Chen across 8 procedure codes in 2024, for 385 Medicare patients. Medicare paid $54,515 for them. Every service was in an office.

CMS counts 385 Medicare patients who saw Dr. Chen in 2024. The largest group is 65 to 74, with 207 patients. 75% of them have high cholesterol, and 66% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.14, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Chen's median patient age at 63, with 8% women.

In 2024, Dr. Chen wrote 510 Medicare Part D claims for 193 patients. 92% of them were for generic drugs. CMS names the drug for 420 of them, across 10 drugs with 11 or more claims each, at $35,650 in total drug cost. In 2023, CMS named 382 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Chen for performance year 2024, reported as part of a group. Dr. Chen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chen as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 24 papers to Dr. Chen, published from 2012 to 2024. 2021 was the busiest year, with 9. The most frequent topics are Fathers, Metabolic Syndrome and Testosterone. Dr. Chen has published most often in J Sex Med. Dr. Chen's most frequent co-authors are Michael Louis Eisenberg, MD, Michael Eisenberg, MD and Evan Anthony Mulloy, MD.

CMS Open Payments shows 42 general payments to Dr. Chen from 10 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 52% of the total. Coloplast Corp paid the most, $1,546.

Dr. Chen graduated from UC San Diego School of Medicine in 2014. Dr. Chen is a member of AUA.

Dr. Chen is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.